Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study.
Agger MPejstrup, Danielsen ERubæk, Carstensen MSchultz, N Nguyen M, Horning M, Henney MAlexander, Jensen CBoe Ravn, Baandrup AOhlhues, Kjær TWesenberg, Madsen KHougaard, et al.
